Article info
PDFShort report
Allele-specific wild-type blocker quantitative PCR for highly sensitive detection of rare JAK2 p.V617F point mutation in primary myelofibrosis as an appropriate tool for the monitoring of molecular remission following therapy
- Correspondence to Udo Siebolts, Institute of Pathology, University of Leipzig, Liebigstrasse 26, Leipzig 04103, Germany; udo.siebolts{at}uniklinik-leipzig.de
Citation
Allele-specific wild-type blocker quantitative PCR for highly sensitive detection of rare JAK2 p.V617F point mutation in primary myelofibrosis as an appropriate tool for the monitoring of molecular remission following therapy
Publication history
- Accepted November 16, 2009
- First published March 30, 2010.
Online issue publication
August 10, 2020
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.